Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

Annals of Oncology - Tập 17 - Trang 1103-1110 - 2006
F.A. Calvo1, F.J. Serrano2, J.A. Diaz-González2, M. Gomez-Espi2, E. Lozano2, R. Garcia2, D. de la Mata2, J.A. Arranz3, P. García-Alfonso3, G. Pérez-Manga3, E. Álvarez4
1Department of Oncology
2Radiation Oncology Service;
3Medical Oncology Service
4Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Tài liệu tham khảo

Valentini, 2002, Does down-staging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients, Int J Radiat Oncol Biol Phys, 53, 664, 10.1016/S0360-3016(02)02764-5 Wagman, 1998, Sphincter preservation with pre-operative radiation therapy (RT) and coloanal anastomoses: long term follow up, Int J Radiat Oncol Biol Phys, 42, 51, 10.1016/S0360-3016(98)00180-1 Janjan, 1999, Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M, D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys, 44, 1027, 10.1016/S0360-3016(99)00099-1 Bosset, 2000, Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial, Int J Raidat Oncol Biol Phys, 46, 323, 10.1016/S0360-3016(99)00411-3 Chari, 1995, Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum, Ann Surg, 221, 778, 10.1097/00000658-199506000-00016 Grann, 2001, Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma, Int J Radiat Oncol Biol Phys, 49, 987, 10.1016/S0360-3016(00)01529-7 Stryker, 1996, Preoperative ‘chemoradiation’ for stages II and III rectal carcinoma, Arch Surg, 131, 514, 10.1001/archsurg.1996.01430170060012 Extra, 1990, Phase I study of oxaliplatin in patients with advanced cancer, Cancer Chemother Pharmacol, 25, 299, 10.1007/BF00684890 Keam, 2005, Oxaliplatin: in operable colorectal cancer, Drugs, 65, 89, 10.2165/00003495-200565010-00005 de Gramont, 2000, Leucorovin and fluorouracil with or without oxaliplatin as first-line treatment of advanced colorectal cancer, J Clin Oncol, 18, 2938, 10.1200/JCO.2000.18.16.2938 André, 2004, Oxaliplatin, fluorouracil and lencovorin as adjuvant treatment of colon cancer, N Engl J Med, 350, 2343, 10.1056/NEJMoa032709 Calvo, 2003, Neoadjuvant oxaliplatin + 5FU followed by chemo-radiation in rectal cancer post-resection p stage pTsize and degree of histological residue, Proc Am Soc Clin Oncol, 1359 Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Bujko, 2004, Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs, conventionally fractionated radiochemotherapy. Radiother Oncol, 72, 15, 10.1016/j.radonc.2003.12.006 Gerard, 2005, Preoperative chemoradiotherapy (CT-RT) improves local control in T3-4 rectal cancer results of the FFCD 9203 randomized trial, Int J Radiat Oncol Biol Phys, 63, s2, 10.1016/j.ijrobp.2005.07.010 Calvo, 2001, Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-fluorouracil vs, tegafur. Int. J Radiat Oncol Biol Phys, 51, 1264, 10.1016/S0360-3016(01)01728-X Chau, 2006, Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer, J Clin Oncol, 24, 668, 10.1200/JCO.2005.04.4875 Aschele, 2005, A phase I-II study of weekly oxaliplatin, 5-Fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer, Ann Oncol, 16, 1140, 10.1093/annonc/mdi212 Machiels, 2005, Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study, Ann Oncol, 16, 1898, 10.1093/annonc/mdi406 Calvo, 2005, Neoadjuvant oxaliplatin (FOLFOX-4) followed by chemoradiation in locally advanced rectal cancer intermediate results, Proc Am Soc Clin Oncol, 3621 Calvo, 2002, Intraoperative presacral electrón boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome análisis, Radiother Oncol, 62, 201, 10.1016/S0167-8140(01)00477-7 1995, LENT SOMA scales for all anatomical sites, Int J Radiat Oncol Biol Phys, 31, 1049, 10.1016/0360-3016(95)90159-0 Mandard, 1994, Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma, Clinicopathologic correlations. Cancer, 73, 2680 Valentini, 2001, Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies, Int J Radiat Oncol Biol Phys, 51, 371, 10.1016/S0360-3016(01)01618-2 Janjan, 1999, Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer, Radiother Oncol, 51, 153, 10.1016/S0167-8140(99)00054-7 Diaz-González, 2005, Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients T3/4 rectal cancer, Int J Radiat Oncol Biol Phys, 61, 1378, 10.1016/j.ijrobp.2004.08.018 Crane, 2003, Response to preoperative chemoradiation increase the use of sphincter preserving surgery in patients with locally advanced low rectal carcinoma, Cancer, 97, 517, 10.1002/cncr.11075 Francois, 1999, Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial, J Clin Oncol, 17, 2396, 10.1200/JCO.1999.17.8.2396 Marijnen, 2001, No downstaging after short-term preoperative radiotherapy in rectal cancer patients, J Clin Oncol, 19, 1976, 10.1200/JCO.2001.19.7.1976 Nagtegaal, 2002, Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer, J Pathol, 197, 20, 10.1002/path.1098 Glehen, 2003, Long-term results of the Lyons R90-01 randomized trail of preoperative radiotherapy and delayed surgery and its effect on sphincter-saving surgery in rectal cancer, Br J Surg, 90, 996, 10.1002/bjs.4162 1997, Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer, N Engl J Med, 336, 980, 10.1056/NEJM199704033361402 Berger, 1997, Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD), Prognostic implications. Int J Radiat Oncol Biol Phys, 37, 619, 10.1016/S0360-3016(96)00577-9 Kapiteijn, 2001, Preoperative readiotherapy combined with total mesorectal escision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Gerard, 2004, Chapet 0, Nemoz C et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial, J Clin Oncol, 22, 2404, 10.1200/JCO.2004.08.170 Kim, 2002, Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer, Int J Radiat Oncol Biol Phys, 54, 403, 10.1016/S0360-3016(02)02856-0 De laTorre, 1999, Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer, Int J Radiat Oncol Biol Phys, 45, 629, 10.1016/S0360-3016(99)00225-4 Feliu, 2002, Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy, Ann Oncol, 13, 730, 10.1093/annonc/mdf116 Fernández-Martos, 2004, Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up, J Clin Oncol, 22, 3016, 10.1200/JCO.2004.11.124 Nakfoor, 1998, The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer, Ann Surg, 228, 194, 10.1097/00000658-199808000-00008 Vecchio, 2005, The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer, Int J Radiat Oncol Biol Phys, 62, 752, 10.1016/j.ijrobp.2004.11.017 Shia, 2004, Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome, Am J Surg Pathol, 28, 215, 10.1097/00000478-200402000-00009 Bosset, 2005, Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921, J Clin Oncol, 23, 5620, 10.1200/JCO.2005.02.113 Minsky, 2003, Oxaliplatin-based combined-modality therapy for rectal cancer, Semin Oncol, 30, 26, 10.1016/S0093-7754(03)00402-0 Gambacorta, 2004, Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: phase I and II studies, Int J Radiat Oncol Biol Phys, 60, 139, 10.1016/j.ijrobp.2004.01.051 Loi, 2005, Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastastic rectal cancer: a phase I trial, Br J Cancer, 92, 655, 10.1038/sj.bjc.6602413 Reerink, 2005, Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study. Anticancer Res, 25, 629 Carraro, 2002, Radiochemotherapy with short daily infusión of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study, Int J Radiat Oncol Biol Phys, 54, 397, 10.1016/S0360-3016(02)02933-4 Rödel, 2003, Phase I-II trial capecitabine, oxaliplatin, and radiation for rectal cancer, J Clin Oncol, 21, 3098, 10.1200/JCO.2003.02.505 Gerard, 2003, Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon RO-04 phase II trial, J Clin Oncol, 21, 1119, 10.1200/JCO.2003.10.045 Francois, 2005, Groupe Digestif de la Federation Nationale des Centres de Lutte Contre le Cancer. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study, Eur J Cancer, 41, 2861, 10.1016/j.ejca.2005.08.029 Glynne-Jones, 2006, A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer, Ann Oncol, 17, 50, 10.1093/annonc/mdj031 Chau, 2006, Neoadjuvant capecitabine and oxalinplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined post-risk rectal cancer, J Clin Oncol, 24, 668, 10.1200/JCO.2005.04.4875 Rödel, 2005, Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer, J Clin Oncol, 23, 8688, 10.1200/JCO.2005.02.1329 Calvo, 2004, 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation, Int J Radiat Oncol Biol Phys, 58, 528, 10.1016/j.ijrobp.2003.09.058 Chessin, 2005, Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response a prospective analysis, Proc Am Soc Clin Oncol, 3612 Bonnen, 2004, Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients, Int J Radiat Oncol Biol Phys, 60, 1098, 10.1016/j.ijrobp.2004.04.062 Ghadimi, 2005, Effectiveness of gene expresion profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy, J Clin Oncol, 23, 1826, 10.1200/JCO.2005.00.406